<DOC>
	<DOCNO>NCT00760786</DOCNO>
	<brief_summary>The purpose study determine whether intensive lipid lower Omega-3 fatty acid effective treatment coronary atherosclerotic plaque .</brief_summary>
	<brief_title>Effects Intensive Lipid Lowering Omega-3 Fatty Acid Composition Coronary Atherosclerotic Plaque</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Acute coronary syndrome within 48 hour symptom onset Have de novo nonculprit coronary artery stenosis 20 % 70 % visual estimation Cardiogenic shock ST segment elevation myocardial infarction within 1 week Hematologic disorder : neutropenia ( neutrophil &lt; 3000/mm3 ) , thrombocytopenia ( platelet &lt; 100,000/mm3 ) Liver enzyme elevation : serum aspartate aminotransferase alanine aminotransferase concentration 3 time upper limit normal Impaired renal function serum creatinine &gt; 2mg/dL Bleeding diathesis history coagulopathy Pregnancy Hypersensitivity heparin , dye , aspirin , clopidogrel , statin , fish</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>IVUS-VH</keyword>
	<keyword>Plaque characterization</keyword>
	<keyword>Omega3-fatty acid</keyword>
	<keyword>Atorvastatin</keyword>
</DOC>